Report Sellers has added a new market research report “Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Forecast to 2025” to its offerings. The report is an in-depth market study providing accurate market insights including the latest trends, forecast, competitive insights, etc.
The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.
The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.
Global Liquid Biopsy Market & Forecast - by Circulating Biomarker
https://www.reportsellers.com/market-research-report/Liquid-Biopsy-Market
This 305 Page report with 118 Figures and 7 Tables has been analyzed from 15 viewpoints:
1. Global Liquid Biopsy Market & Forecast (2015 - 2025)
2. Global Liquid Biopsy Market Share & Forecast (2015 - 2025)
3. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2025)
4. Global Liquid Biopsy Market & Forecast - by Product (2015 - 2025)
5. Global Liquid Biopsy Market & Forecast - by Application (2015 - 2025)
6. Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types (2015 - 2025)
7. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2025)
8. Global Liquid Biopsy Market & Forecast - by End User (2015 - 2025)
9. Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2025)
10. Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2025)
11. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2015 - 2025)
12. Liquid Biopsy Initiatives
13. Liquid Biopsy Companies Financing Details
14. 20 Company Profiles
15. Global Liquid Biopsy Market - Driving Factors & Challenges
Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2025)
1. Circulating Tumor Cells (CTCs)
2. Circulating Tumor DNA (ctDNA)
3. Cell-Free DNA (cfDNA)
4. Extracellular Vesicles (EVs)
5. Other Circulating Biomarkers
Global Liquid Biopsy Market & Forecast - by Product (2015 - 2025)
1. Kits and Consumables
2. Instruments
3. Services
Global Liquid Biopsy Market & Forecast - by Application (2015 - 2025)
1. Oncology Application
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Gastrointestinal Cancer
Leukaemia
Others
2. Non-Cancer Application
Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2025)
1. Therapy Selection
2. Treatment Monitoring
3. Early Cancer Screening
4. Recurrence Monitoring
Global Liquid Biopsy Market & Forecast - by End User (2015 - 2025)
1. Reference Laboratories
2. Hospitals and Physician Laboratories
3. Academic and Research Centers
4. Other End Users
Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2025)
1. Blood Sample
2. Urine Sample
3. Other Fluids Sample
Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2025)
1. North America
2. Asia Pacific
3. Europe
4. Middle East & Africa
5. Latin America
Liquid Biopsy Market - Company Profiles
1. Personal Genome Diagnostics
2. Guardant Health, Inc.
3. Pathway Genomics
4. RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)
5. Trovagene, Inc
6. Cynvenio Biosystems, Inc.
7. Biocept, Inc.
8. ANGLE plc
9. MDxHealth
10. Clearbridge BioMedics Pte Ltd
11. Exosome Diagnostics, Inc
12. Foundation Medicine, Inc
13. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
14. Genomic Health
15. Myriad Genetics, Inc
16. Thermo Fisher Scientific, Inc
17. QIAGEN NV
18. Bio-Rad Laboratories, Inc
19. Menarini-Silicon Biosystems
20. GRAIL
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
About Report Sellers
Report Sellers is a premium market research service provider offering market reports in varied sectors. We have a team of experienced analysts and publishers who continuously track the latest trends in different industries.
Report Sellers is a brand of global repute and offers the best suited research services to its clients globally in the most satisfying manner. We have a strong network of industry experts who have successfully delivered complex research assignments in niche and top markets.
For more information, contact
Report Sellers
Email: sales@reportsellers.com
Direct: +1-214-396-2385
The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.
The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.
Global Liquid Biopsy Market & Forecast - by Circulating Biomarker
- Based on circulating biomarkers, the global liquid biopsy market is being dominated by Circulating Tumor Cells (CTCs).
- The circulating tumor DNA (ctDNA) is the second largest segment of the liquid biopsy market.
- The cell free DNA (cfDNA) is the third largest segment of the liquid biopsy market.
- The extracellular vesicles (EVs) segment is the fastest growing segment during the forecast period.
- The global liquid biopsy market, by product, is being dominated by Kits and Consumable.
- The instruments segment is likely to witness highest growth in the global liquid biopsy market.
- The services segment captured least share of the liquid biopsy market.
- The global liquid biopsy market, by application, is being dominated by oncology application.
- Lung cancer and breast cancer accounts for largest share of the liquid biopsy oncology market.
- The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.
- On the basis of clinical application, the therapy selection segment is expected to account for largest share of the liquid biopsy market throughout the forecasting period.
- Treatment monitoring captured second highest share of the liquid biopsy market in 2017, being followed by the early cancer screening application.
- Recurrence monitoring captured least share of the liquid biopsy market.
- In 2017, Reference laboratories captured largest share of the global liquid biopsy market.
- Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2017, being followed by Academic and Research Centers.
- Blood is the most widely used sample type and is expected to remain the largest market during the forecasting period as well.
- The urine sample segment is anticipated to witness noticeable growth throughout the forecasting period.
- North America accounted for largest share of the global liquid biopsy market in 2017, followed by Europe.
- In North America, United States accounted for largest share of the liquid biopsy market.
- In Europe, Germany and France are the leading market for liquid biopsy.
- Asia pacific is likely to be the fastest growing market for liquid biopsy during the forecasting period.
- In Asia Pacific, Japan and China are the leading market for liquid biopsy.
- Latin America is the fourth largest market for liquid biopsy, being followed by Middle East & Africa.
https://www.reportsellers.com/market-research-report/Liquid-Biopsy-Market
This 305 Page report with 118 Figures and 7 Tables has been analyzed from 15 viewpoints:
1. Global Liquid Biopsy Market & Forecast (2015 - 2025)
2. Global Liquid Biopsy Market Share & Forecast (2015 - 2025)
3. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2025)
4. Global Liquid Biopsy Market & Forecast - by Product (2015 - 2025)
5. Global Liquid Biopsy Market & Forecast - by Application (2015 - 2025)
6. Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types (2015 - 2025)
7. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2025)
8. Global Liquid Biopsy Market & Forecast - by End User (2015 - 2025)
9. Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2025)
10. Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2025)
11. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2015 - 2025)
12. Liquid Biopsy Initiatives
13. Liquid Biopsy Companies Financing Details
14. 20 Company Profiles
15. Global Liquid Biopsy Market - Driving Factors & Challenges
Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2025)
1. Circulating Tumor Cells (CTCs)
2. Circulating Tumor DNA (ctDNA)
3. Cell-Free DNA (cfDNA)
4. Extracellular Vesicles (EVs)
5. Other Circulating Biomarkers
Global Liquid Biopsy Market & Forecast - by Product (2015 - 2025)
1. Kits and Consumables
2. Instruments
3. Services
Global Liquid Biopsy Market & Forecast - by Application (2015 - 2025)
1. Oncology Application
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Gastrointestinal Cancer
Leukaemia
Others
2. Non-Cancer Application
Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2025)
1. Therapy Selection
2. Treatment Monitoring
3. Early Cancer Screening
4. Recurrence Monitoring
Global Liquid Biopsy Market & Forecast - by End User (2015 - 2025)
1. Reference Laboratories
2. Hospitals and Physician Laboratories
3. Academic and Research Centers
4. Other End Users
Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2025)
1. Blood Sample
2. Urine Sample
3. Other Fluids Sample
Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2025)
1. North America
2. Asia Pacific
3. Europe
4. Middle East & Africa
5. Latin America
Liquid Biopsy Market - Company Profiles
1. Personal Genome Diagnostics
2. Guardant Health, Inc.
3. Pathway Genomics
4. RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)
5. Trovagene, Inc
6. Cynvenio Biosystems, Inc.
7. Biocept, Inc.
8. ANGLE plc
9. MDxHealth
10. Clearbridge BioMedics Pte Ltd
11. Exosome Diagnostics, Inc
12. Foundation Medicine, Inc
13. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
14. Genomic Health
15. Myriad Genetics, Inc
16. Thermo Fisher Scientific, Inc
17. QIAGEN NV
18. Bio-Rad Laboratories, Inc
19. Menarini-Silicon Biosystems
20. GRAIL
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Request Sample here:
https://www.reportsellers.com/market-research-report/Liquid-Biopsy-Market
Related Reports
We have a large number of reports in other Diagnostics Industry
which can be accessed in the following link:
https://www.reportsellers.com/sub-category/Diagnostics-market-research-reportAbout Report Sellers
Report Sellers is a premium market research service provider offering market reports in varied sectors. We have a team of experienced analysts and publishers who continuously track the latest trends in different industries.
Report Sellers is a brand of global repute and offers the best suited research services to its clients globally in the most satisfying manner. We have a strong network of industry experts who have successfully delivered complex research assignments in niche and top markets.
For more information, contact
Report Sellers
Email: sales@reportsellers.com
Direct: +1-214-396-2385
